Original Article
Copyright ©2010 Baishideng.
World J Gastroenterol. Feb 21, 2010; 16(7): 837-845
Published online Feb 21, 2010. doi: 10.3748/wjg.v16.i7.837
Figure 1
Figure 1 Pain threshold pressure assessment in different groups. Data are presented as the mean ± SE. Before treatment, the pain threshold of NMS groups was significantly decreased, as compared with that of the NH-VH group (bP < 0.001). After treatment, JCM-16021 and Holopon significantly increased the pain threshold pressure (aP < 0.05, dP < 0.01, fP < 0.001) compared with that before treatment of each group.